Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
8167 items from SEC EDGAR · filings · clear filters
- 8-K - Polaryx Therapeutics, Inc. (0002075320) (Filer)
Automated notePolaryx Therapeutics, Inc. filed a Form 8-K on September 14, 2026 (Accession No. 0001213900-26-099416) reporting Item 5.07, which details the submission of certain matters to a vote of its security holders.
- 8-K/A - BIOLARGO, INC. (0000880242) (Filer)
Automated noteBiolargo, Inc. filed an amended Form 8-K on September 14, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - abrdn Global Infrastructure Income Fund (0001793855) (Filer)
Automated noteabrdn Global Infrastructure Income Fund filed a Form 8-K on September 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - NorthStrive Acquisition Corp I. (0002133719) (Filer)
Automated noteNorthStrive Acquisition Corp I filed a Form 8-K with the SEC on September 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - BIOVIE INC. (0001580149) (Filer)
Automated noteBiovie Inc. filed a Form 8-K on September 14, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.
- 8-K - InPoint Commercial Real Estate Income, Inc. (0001690012) (Filer)
Automated noteInPoint Commercial Real Estate Income, Inc. filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure, other events, and financial statements and exhibits.
- 8-K - Synchrony Financial (0001601712) (Filer)
Automated noteSynchrony Financial filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - TransparentBusiness, Inc. (0001740742) (Filer)
Automated noteTransparentBusiness, Inc. filed a Form 8-K on September 14, 2026 reporting departures, elections, appointments, and compensation arrangements for certain officers under Item 5.02.
- 8-K - Fly-E Group, Inc. (0001975940) (Filer)
Automated noteFly-E Group, Inc. filed an 8-K reporting departures, elections or appointments of directors and certain officers, along with related compensatory arrangements, and provided its financial statements and accompanying exhibits.
- 8-K - SharonAI Holdings Inc. (0002068385) (Filer)
Automated noteSharonAI Holdings Inc. filed a Form 8-K reporting entry into a material definitive agreement, the departure and appointment of directors and certain officers with related compensation arrangements, and the inclusion of financial statements and exhibits.
- 8-K - DeFi Development Corp. (0001805526) (Filer)
Automated noteDeFi Development Corp. filed a Form 8-K on September 11, 2026, reporting entry into a material definitive agreement, amendments to its articles of incorporation/bylaws, including a fiscal year change, and accompanying financial statements and exhibits.
- 8-K - T3 Defense Inc. (0001787518) (Filer)
Automated noteT3 Defense Inc. filed a Form 8-K on September 11, 2026, reporting the creation of a direct financial obligation or off-balance-sheet arrangement and including its financial statements and related exhibits.
- 8-K - KULR Technology Group, Inc. (0001662684) (Filer)
Automated noteKULR Technology Group, Inc. filed a Form 8-K reporting the completion of an acquisition or disposition of assets and disclosing departures, elections, appointments, and compensatory arrangements for certain directors and officers.
- 8-K - Volato Group, Inc. (0001853070) (Filer)
Automated noteVolato Group, Inc. filed an 8-K reporting a material definitive agreement, completion of an acquisition, a new financial obligation, unregistered equity sales, modifications to security holder rights, and changes to directors and officers with related compensation arrangements.
- 8-K - Greenwave Technology Solutions, Inc. (0001589149) (Filer)
Automated noteGreenwave Technology Solutions, Inc. filed an 8-K reporting unregistered sales of equity securities, amendments to its articles of incorporation or bylaws and a fiscal year change, other events, and accompanying financial statements and exhibits.
- 8-K - VISIUM TECHNOLOGIES, INC. (0001082733) (Filer)
Automated noteVisium Technologies, Inc. filed a Form 8-K reporting material modifications to security holders’ rights, amendments to its articles of incorporation or bylaws including a fiscal year change, and accompanying financial statements and exhibits.
- 8-K - IMMUNIC, INC. (0001280776) (Filer)
Automated noteImmune, Inc. filed a Form 8-K on September 11, 2026, disclosing departures, elections, appointments and compensatory arrangements for certain officers, and providing its financial statements and related exhibits.
- 8-K - Glucotrack, Inc. (0001506983) (Filer)
Automated noteGlucotrack, Inc. filed a Form 8-K reporting a material definitive agreement, the creation of a direct financial obligation/off-balance sheet arrangement, unregistered sales of equity securities, a Regulation FD disclosure, and related financial statements and exhibits.
- 8-K - Amesite Inc. (0001807166) (Filer)
Automated noteAmesite Inc. filed a Form 8-K on September 11, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Banzai International, Inc. (0001826011) (Filer)
Automated noteBanzai International, Inc. filed a Form 8-K on September 11, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.
- 8-K - Brightline Interactive, Inc./NV (0001854445) (Filer)
Automated noteBrightline Interactive, Inc. filed an 8-K reporting a notice of delisting or failure to satisfy a continued listing rule and the company's plan to transfer its listing.
- 8-K - ACADIA PHARMACEUTICALS INC (0001070494) (Filer)
Automated noteAcadia Pharmaceuticals Inc. filed a Form 8-K with the SEC on September 11 2026 (Accession No. 0001193125-26-389400), containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - GMR Solutions Inc. (0001898718) (Filer)
Automated noteGMR Solutions Inc. filed a Form 8-K on September 11, 2026, reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.
- 8-K - Flux Power Holdings, Inc. (0001083743) (Filer)
Automated noteFlux Power Holdings, Inc. filed a Form 8-K on September 11, 2026 disclosing departures, elections, and appointments of directors and certain officers, along with related compensatory arrangements for those officers.
- 8-K - COTY INC. (0001024305) (Filer)
Automated noteCoty Inc. filed a Form 8-K on September 11, 2026, disclosing departures and appointments of certain directors and officers, related compensatory arrangements, and providing its financial statements and accompanying exhibits.
- 8-K/A - BELDEN INC. (0000913142) (Filer)
Automated noteBelden Inc. filed a Form 8-K/A on September 11, 2026, providing updated financial statements and related exhibits under Item 9.01.
- 8-K - FLEXSTEEL INDUSTRIES INC (0000037472) (Filer)
Automated noteFlexsteel Industries Inc. filed a Form 8-K on September 11, 2026, reporting director and officer departures, appointments and compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K/A - VISIUM TECHNOLOGIES, INC. (0001082733) (Filer)
Automated noteVisium Technologies, Inc. filed a Form 8-K/A on September 11, 2026, reporting unregistered sales of equity securities, amendments to its articles of incorporation or bylaws and fiscal year, other events, and accompanying financial statements and exhibits.
- 8-K - Transcode Therapeutics, Inc. (0001829635) (Filer)
Automated noteTranscode Therapeutics filed a Form 8-K reporting departures, elections, appointments and related compensation arrangements for certain officers, along with its financial statements and exhibits.
- 8-K - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)
Automated noteIntelligent Bio Solutions Inc. submitted a Form 8-K filing under Item 8.01 (Other Events) on September 11, 2026, accession number 0001493152-26-042411, comprising a 197 KB document.